Until now, immunity against new coronavirus; SARS-COV-2 was mostly centered around the antibody response. A recent study from Karolinska Institute highlighted the immune response against SARS-COV-2 is not limited to the antibody production. 200 people from blood donors as well as some infected people has been tested for both antibodies and T-cell response against SARS-nCOV-2. Study showed that 30% of the blood donors tested had reactive T-cells against the new coronavirus, even if they had undetectable levels of antibodies.
Although this is great news that immunity against SARS-COV-2 might be higher than we thought we still have a lot to learn.
Whether to see complete picture how immune system reacts to the new coronavirus or to develop a vaccine or therapeutic agents, scientists need reliable and specific tools.
View Nordic BioSite’s excellent selection of tetramers and SARS-COV-2 peptides to track specific T-cells and to monitor vaccine candidates.
|Name / Allele||Cat #|
|Flex-T™ HLA-A*01:01 Monomer UVX||280001|
|Flex-T™ HLA-A*11:01 Monomer UVX||280007|
|Flex-T™ Biotin HLA-A*02:01 SARS-Cov-2 Monomer (VLNDILSRL)||280029|
|Custom Biotinylated Monomer – DRB1*01:01 (CP)||TBCM6-R1011C-M|
Immune Detection Reagents for COVID-19 Research
|SPC017||Class I||LLLDDFVEII||SARS-CoV-2 ORF1ab (6749-6758)||Peptide|
|SPC016||Class I||FLLNKEMYL||SARS-CoV-2 ORF1ab (3183-3191)||Peptide|
|SPC015||Class I||FLAHIQWMV||SARS-CoV-2 ORF1ab (3122-3130)||Peptide|
|SPC014||Class II||YFTSDYYQLYSTQLS||SARS-CoV-2 ORF3a protein (206-220)||Peptide|
|SPC013||Class II||WPQIAQFAPSASAFF||SARS-CoV-2 nucleocapsid phosphoprotein (301-315)||Peptide|
|SPC012||Class II||TRFQTLLALHRSYLT||SARS-CoV-2 chain A spike glycoprotein (236-250)||Peptide|